Procaps Group, S.A Total Non-Operating Income/Expense 2020-2023 | PROCF

Procaps Group, S.A total non-operating income/expense from 2020 to 2023. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
Procaps Group, S.A Annual Total Non-Operating Income/Expense
(Millions of US $)
2022 $13
2021 $-158
2020 $-62
2020 $-12
2019 $-47
2019 $
2018 $
Procaps Group, S.A Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2023-09-30 $-2
2023-06-30 $23
2023-03-31 $6
2022-12-31 $7
2022-09-30 $13
2022-06-30 $-27
2022-03-31 $20
2021-12-31 $-1
2021-09-30 $-126
2021-06-30 $-16
2021-03-31 $-15
2020-12-31 $-6
2020-09-30 $-16
2020-06-30 $-4
2020-03-31 $3
2019-12-31
2019-09-30
2019-06-30
2019-03-31
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.125B $0.410B
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
Stock Name Country Market Cap PE Ratio
NextEra Energy Partners, LP (XIFR) United States $0.828B 4.49